ICON announces release of ADDPLAN® neo
Software provides an integrated technology platform for adaptive clinical trials
ICON Confirms Retirement of Co-Founder Dr. Ronan Lambe
After 28 years of Service
ICON Reports Second Quarter 2018 Results
Q2 2018 Financial Results
ICON and DIA driving Insights to Action with DIA Live 2018
Social media aggregation site will highlight real-time digital conversations at DIA 2018
ICON enhances Endpoint Adjudication Services
Agreement to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality
ICON Launches FIRECREST Financial Disclosure
The solution enables secure, centralised, electronic distribution and response capture of Financial Disclosure information.
ICON named by Forbes as one of the best employers in America
Forbes ranking of top employers drawn from a survey of 30,000 US employees in 25 industry sectors
ICON Announces Clinical Research partnership with DuPage Medical Group
Additional PMG Research site locations enhances ICON’s site and patient engagement capabilities
ICON sponsors industry-wide clinical trials survey to support Transforming Trials initiative
A new survey of pharmaceutical executives and professionals by ICON and Pharma Intelligence, which examines the key challenge of declining research and development (R&D) efficiency.
ICON Reports First Quarter 2018 Results
Q1 2018 Financial Results